N6-methyladenosine (m6A) RNA modification in cancer stem cells [PDF]
Zhonghua Ma, Jiafu Ji
openalex +1 more source
The N‐acetyltransferase‐10 (NAT10)‐mediated mRNA N4‐acetylcytidine modification enhances the stability of CXCL2 and KLF5 mRNA. Then, secreted CXCL2 promotes M2 macrophage polarization and oncostatin M secretion, activating NAT10 expression via STAT3 signaling.
Chen Chen+17 more
wiley +1 more source
FTO-mediated SMAD2 m6A modification protects cartilage against Osteoarthritis
N6-methyladenosine (m6A) modification is one of the most prevalent forms of epigenetic modification and plays an important role in the development of degenerative diseases such as osteoarthritis (OA).
Hongyi Zhou+10 more
doaj +1 more source
Regulation of Viral Infection by the RNA Modification N6-Methyladenosine [PDF]
Graham D. Williams+2 more
openalex +1 more source
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer [PDF]
Jiangfeng Li+12 more
openalex +1 more source
This study unveiled the mechanism by which circDNA2‐educated YTHDF2 phase separation promotes PM2.5‐induced malignant transformation in HBE cells by blunting GADD45A expression, providing definitive evidence for the first time that LLPS is involved in the induction of tumorigenesis by particulate pollutants. Moreover, the clinical value of circDNA2 and
Jie Xu+5 more
wiley +1 more source
Connecting N6‐methyladenosine modification to ferroptosis resistance in hepatoblastoma
Wan‐Xin Peng, Yin‐Yuan Mo
doaj +1 more source
N6-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling [PDF]
Abhirami Visvanathan+4 more
openalex +1 more source
N6-Methyladenosine Modification of Fatty Acid Amide Hydrolase Messenger RNA in Circular RNA STAG1–Regulated Astrocyte Dysfunction and Depressive-like Behaviors [PDF]
Rongrong Huang+12 more
openalex +1 more source
The long non‐coding RNA (lncRNA) CD2BP2‐DT is upregulated in breast cancer and correlates with poor patient prognosis. Mechanistically, CD2BP2‐DT drives YBX1 phase separation to stabilize CDK1 and promote breast cancer progression. Moreover, NAT10‐mediated N4‐acetylcytosine (ac4C) modification further enhances CD2BP2‐DT expression.
Hongyu Wang+9 more
wiley +1 more source